Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (51-60 of 357) with videos related to

Pageof 36
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2021
Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related EnteropathyHisham J Akhtar, Tran M Nguyen, Christopher Ma, et al.
Inflammatory Intestinal Diseases|February 28, 2022
Early Laparoscopic Ileal Resection for Localized Ileocecal Crohn's Disease: Hard Sell or a Revolutionary New Norm?Beatriz Yuki Maruyama, Christopher Ma, Remo Panaccione, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2021
Editorial: use of intestinal ultrasound in the scoring of Crohn's disease activity in clinical trials - is it ready for prime time yet? Authors' replyThomas M Goodsall, Vipul Jairath, Robert V Bryant, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2018
Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximabBrian G Feagan, Gordon Lam, Christopher Ma, et al.
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?Christopher Ma, Remo Panaccione, Reena Khanna, et al.
Journal of the American Chemical Society|January 22, 2004
Single-crystal CdSe nanosawsChristopher Ma, Yong Ding, Daniel Moore, et al.
The American Journal of Gastroenterology|January 14, 2021
Gender Disparities in Food Security, Dietary Intake, and Nutritional Health in the United StatesChristopher Ma, Stephanie K M Ho, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 10, 2021
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysisJoseph Meserve, Christopher Ma, Parambir S Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 12, 2018
Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to VedolizumabChristopher Ma, Paulo G Kotze, Abdulelah Almutairdi, et al.
Current Opinion in Pharmacology|February 17, 2022
Eosinophilic esophagitis: New molecules, better life?Angela Y Lam, Christopher Ma, Jeffrey K Lee, et al.
Pageof 36

Showing results (51-60 of 357) with videos related to

Sort By:
Pageof 36
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2021
Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related EnteropathyHisham J Akhtar, Tran M Nguyen, Christopher Ma, et al.
Inflammatory Intestinal Diseases|February 28, 2022
Early Laparoscopic Ileal Resection for Localized Ileocecal Crohn's Disease: Hard Sell or a Revolutionary New Norm?Beatriz Yuki Maruyama, Christopher Ma, Remo Panaccione, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2021
Editorial: use of intestinal ultrasound in the scoring of Crohn's disease activity in clinical trials - is it ready for prime time yet? Authors' replyThomas M Goodsall, Vipul Jairath, Robert V Bryant, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2018
Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximabBrian G Feagan, Gordon Lam, Christopher Ma, et al.
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?Christopher Ma, Remo Panaccione, Reena Khanna, et al.
Journal of the American Chemical Society|January 22, 2004
Single-crystal CdSe nanosawsChristopher Ma, Yong Ding, Daniel Moore, et al.
The American Journal of Gastroenterology|January 14, 2021
Gender Disparities in Food Security, Dietary Intake, and Nutritional Health in the United StatesChristopher Ma, Stephanie K M Ho, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 10, 2021
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysisJoseph Meserve, Christopher Ma, Parambir S Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 12, 2018
Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to VedolizumabChristopher Ma, Paulo G Kotze, Abdulelah Almutairdi, et al.
Current Opinion in Pharmacology|February 17, 2022
Eosinophilic esophagitis: New molecules, better life?Angela Y Lam, Christopher Ma, Jeffrey K Lee, et al.
Pageof 36